University of Tennessee

Cytogenetic biodosimetry provides a biological measure of radiation-induced DNA damage; however, its application in clinical proton therapy patients remains limited. The purpose of this study was to establish a longitudinal framework for assessing chromosomal...

Adaptive radiotherapy (ART) decisions made during quality assurance CT (QACT) review are commonly documented in free‑text clinical notes. Automated classification of these rationales could enable large‑scale workflow and quality‑improvement analysis. However,...

Respiratory motion and delivery dynamics can affect delivered dose in scanned proton therapy, particularly for thoracic treatments. Many existing motion-evaluation approaches rely on simplified delivery assumptions or research-only implementations, limiting t...

Translation of tissue and tumor dose-response thresholds from external-beam radiation therapy (EBRT) to radiopharmaceutical therapies (RPTs) for dose optimization requires accurate values of relative biological effectiveness (RBE), which are still not known p...